The secondary outcomes will focus on changes of following obesity related measurements between baseline and post treatment: mean weight reduction, body mass index (BMI), body fat, waist and hip circumferences, lipid profile, C-Reactive protein (CRP), volume of visceral fat, Korean version of Obesity-related Quality of Life (KOQoL), The Korean Version of Eating Attitudes Test-26 (KEAT-26). This evidence concerns the gene CRP and obesity disorder.